Controlled Substances Amendments House Bill (HB) 260 This bill adds gabapentin to the list of controlled substances (CS) as a Schedule V drug. Each pharmacy that dispenses gabapentin will need to ensure that they also have an active Utah Dispensing Controlled Substance License in connection to the Utah pharmacy license. State of Utah Laws and Rules relating to the prescribing of Controlled Substances. 1 - (Aminomethyl)-cyclohexane acetic acid (Gabapentin) is still a non-controlled substance. It is not "Scheduled" Federally or in State Statute, it is still a legend drug regulated by the FDA by general Rx order. At this time there is no change or new regulation with prescribing gabapentin. H.B. 260 House Floor Audio, Day 18 (2/2/2024) [HB260 Controlled Substances Amendments, Dailey-Provost] Senate Floor Audio, Day 29 (2/13/2024) [HB260 Controlled Substances Amendments, Vickers] In January 2020, The Drug Regimen Review Center (DRRC) published a report on behalf of Utah Medicaid Drug Utilization Review program, titled, “Abuse and Misuse of Gabapentin.” The report includes information on toxic exposures involving gabapentin. ‘Exposure’ is a common term in clinical toxicology and emergency medicine, wherein a chemical substance comes into contact with the body We would like to show you a description here but the site won’t allow us. Gabapentin isn’t considered a controlled substance by the federal government as of July 2022. But several states consider gabapentin a schedule V (schedule 5) controlled substance. The Controlled Substance Database (CSD) administrator provided a summary of available data on gabapentin dispensing, including 554,879 prescriptions dispensed between Q3 2020, and Q2 2021 (“one year”). Based on data in the CSD, gabapentin is dispensed most commonly to patients in the 55-65 year age group (21%), followed by 65-75 year age group (17.7%), and 45-55 age group (17.2%). The 📣 Utah House Bill 260, titled “Controlled Substances Amendments,” has been enacted following approval from both legislative chambers and the Governor’s signature. 📜 The bill introduces Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Utah's Controlled Substance Database Program (CSD) is a resource that assists prescribing practitioners and pharmacists in providing efficient care for their patients and customers usage of controlled substances. The Utah Controlled Substance Database Program was legislatively created and put into effect on July 1, 1995. The CSD collects data on the dispensing of Schedule II-V drugs from all 10 Highlighted Provisions: 11 This bill: 12 < adds gabapentin to Schedule V of the list of controlled substances; and 13 < makes technical and conforming changes. The Controlled Substance Database (CSD) administrator provided a summary of available data on gabapentin dispensing, including 339,108 prescriptions dispensed between Q3 2022, and Q2 2023. This data also indicate that gabapentin is dispensed most commonly to patients in the 55-65 year age group (20%), followed by 45-55 year age group (17%), and 35-45 age group (15%). The majority of Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Authorized practitioners MUST hold a Utah Controlled Substance License and a DEA registration to prescribe, administer, or dispense a controlled substance in the State of Utah. Gabapentin is classified as a controlled substance in several states, including Alabama, Georgia, Kentucky, Tennessee, and Texas. These states have placed it under Schedule V, indicating a lower potential for abuse compared to higher schedules. Utah HB260 2024 General Description This bill adds gabapentin to the list of controlled substances Highlighted Provisions This bill adds gabapentin to Schedule V of 22 administering, or dispensing gabapentin, is exempt from the requirements of this chapter. 23 Section 2. Effective Date. 24 This bill takes effect on May 7, 2025. with respect to gabapentin, exempts veterinarians from the provisions of the Utah Controlled Substances Act. New Subsection R156-37f-203 (7) requires the Utah Controlled Substance Database to track the non-controlled substance prescription drug 1 - (Aminomethyl)-cyclohexaneacetic acid (Gabapentin). New Subsection R156-37f-203 (8) clarifies that the Utah Controlled Substance Database tracks derivatives of barbituric acid (Butalbital).
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |